Literature DB >> 6330925

Age-associated increments in human platelet alpha-adrenoceptor capacity. Possible mechanism for platelet hyperactivity to epinephrine in aging man.

M Yokoyama, A Kusui, S Sakamoto, H Fukuzaki.   

Abstract

In order to evaluate the effects of aging on platelet alpha-adrenergic receptor function, we have examined the binding of [3H]dihydroergocryptine ( [3H]DHE), a nonselective alpha-adrenergic antagonist, to crude platelet membrane at 25 degrees C in 28 subjects of various ages (mean 48, range 21-77 years) and platelet aggregatory response to epinephrine in other 32 subjects of various ages (mean 51, range 27-82 years). The average values of the binding capacity and affinity for [3H]DHE showed 218 +/- 56 fmol/mg protein (mean +/- SD) and 1.80 +/- 0.20 nM, respectively. There was a significant correlation between the binding capacity for [3H]DHE and age (r = 0.654, p less than 0.001). On the contrary, no significant correlation was found between the binding affinity for [3H]DHE and age (r = 0.273, p greater than 0.1). Exaggerated aggregatory response to epinephrine with advancing age was also demonstrated in this study (r = 0.716, p less than 0.001). Thus, the demonstration of increased alpha-adrenergic receptor capacity in aging man offers a possible explanation for the observed age-associated hyperactivity of the platelets to epinephrine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330925     DOI: 10.1016/0049-3848(84)90385-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Ageing and platelet alpha 2-adrenoceptors.

Authors:  C Buckley; D Curtin; T Walsh; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

2.  Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: clinical relevance.

Authors:  N Fetkovska; A Pletscher; F Ferracin; R Amstein; F R Buhler
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

Review 3.  Physiological changes due to age. Implications for cardiovascular drug therapy.

Authors:  I Stolarek; P J Scott; F I Caird
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

Review 4.  Platelet Function in Aging.

Authors:  Jessica Le Blanc; Marie Lordkipanidzé
Journal:  Front Cardiovasc Med       Date:  2019-08-07

5.  Better detection of platelet aggregation in patients with metabolic syndrome using epinephrine and ADP.

Authors:  Laura Perez-Campos-Mayoral; Eduardo Pérez-Campos; Edgar Zenteno; Abraham Majluf-Cruz; Eduardo Perez-Ortega; Diana Matias-Pérez; Francisco J Rodal-Canales; Ruth Martínez-Cruz; Socorro Pina-Canseco; Miguel Angel Reyes Franco; Gabriel Mayoral Andrade; Pedro Hernández; Belem Gallegos
Journal:  Diabetol Metab Syndr       Date:  2014-08-29       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.